Echinocandin antifungal drug resistance

T.M. Rogers, E.M. Johnson, Carol Anne Munro

Research output: Contribution to journalArticle

Abstract

The recent introduction of the echinocandins to clinical practice represents a welcome addition to the antifungal armamentarium. This new class of drugs with their novel mode of antifungal action have several advantages over existing agents. They are most active against the principal invasive fungal pathogens Candida and Aspergillus spp, they have low toxicity for patients, and they have potential value in combination therapy.
Original languageEnglish
Pages (from-to)99-105
JournalJournal of Invasive Fungal Infections
Volume1
Issue number3
Publication statusPublished - Jan 2007

Fingerprint

Fungal Drug Resistance
Echinocandins
Aspergillus
Candida
Pharmaceutical Preparations
Therapeutics

Cite this

Echinocandin antifungal drug resistance. / Rogers, T.M.; Johnson, E.M.; Munro, Carol Anne.

In: Journal of Invasive Fungal Infections, Vol. 1, No. 3, 01.2007, p. 99-105.

Research output: Contribution to journalArticle

Rogers, TM, Johnson, EM & Munro, CA 2007, 'Echinocandin antifungal drug resistance', Journal of Invasive Fungal Infections, vol. 1, no. 3, pp. 99-105.
Rogers, T.M. ; Johnson, E.M. ; Munro, Carol Anne. / Echinocandin antifungal drug resistance. In: Journal of Invasive Fungal Infections. 2007 ; Vol. 1, No. 3. pp. 99-105.
@article{a6d34f63be2249e0b87cbb45e6ef3c38,
title = "Echinocandin antifungal drug resistance",
abstract = "The recent introduction of the echinocandins to clinical practice represents a welcome addition to the antifungal armamentarium. This new class of drugs with their novel mode of antifungal action have several advantages over existing agents. They are most active against the principal invasive fungal pathogens Candida and Aspergillus spp, they have low toxicity for patients, and they have potential value in combination therapy.",
author = "T.M. Rogers and E.M. Johnson and Munro, {Carol Anne}",
year = "2007",
month = "1",
language = "English",
volume = "1",
pages = "99--105",
journal = "Journal of Invasive Fungal Infections",
issn = "1753-3783",
publisher = "Remedica Medical Education and Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Echinocandin antifungal drug resistance

AU - Rogers, T.M.

AU - Johnson, E.M.

AU - Munro, Carol Anne

PY - 2007/1

Y1 - 2007/1

N2 - The recent introduction of the echinocandins to clinical practice represents a welcome addition to the antifungal armamentarium. This new class of drugs with their novel mode of antifungal action have several advantages over existing agents. They are most active against the principal invasive fungal pathogens Candida and Aspergillus spp, they have low toxicity for patients, and they have potential value in combination therapy.

AB - The recent introduction of the echinocandins to clinical practice represents a welcome addition to the antifungal armamentarium. This new class of drugs with their novel mode of antifungal action have several advantages over existing agents. They are most active against the principal invasive fungal pathogens Candida and Aspergillus spp, they have low toxicity for patients, and they have potential value in combination therapy.

M3 - Article

VL - 1

SP - 99

EP - 105

JO - Journal of Invasive Fungal Infections

JF - Journal of Invasive Fungal Infections

SN - 1753-3783

IS - 3

ER -